Bain Capital Life Sciences Investors 13F annual report (2024 ...

$910 billion Assets Under Management (AUM) As of 5th August 2024, Bain Capital Life Sciences Investors’s top holding is 2,697,267 shares of Nuvalent Inc currently worth over $205 billion …

CouponFollow Extension

$910
OFF

Bain Capital Life Sciences Investors 13F Annual Report (2024 ...

1 day from now

$910 billion Assets Under Management (AUM) As of 5th August 2024, Bain Capital Life Sciences Investors’s top holding is 2,697,267 shares of Nuvalent Inc currently worth over $205 billion …

wallmine.com

37%
OFF

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC - WhaleWisdom.com

1 day from now

Their last reported 13F filing for Q3 2024 included $961,175,669 in managed 13F securities and a top 10 holdings concentration of 89.37%. Bain Capital Life Sciences Investors's largest holding …

whalewisdom.com

$910
OFF

Bain Capital Life Sciences Investors 13F Annual Report

1 day from now

$910 billion Assets Under Management (AUM) As of 5th August 2024, Bain Capital Life Sciences Investors’s top holding is 2,697,267 shares of Nuvalent Inc currently worth over $205 billion …

wallmine.com

$1.24
OFF

Bain Capital Life Sciences Investors 13F Annual Report

1 day from now

Bain Capital Life Sciences Investors 13F annual report Bain Capital Life Sciences Investors is an investment fund managing more than $1.24 trillion ran by Adam Koppel. ... As of 8th May …

wallmine.com

$961
OFF

Bain Capital Life Sciences Investors, LLC Q3 2024 13F Top Portfolio ...

1 day from now

Aug 12, 2024 · Bain Capital Life Sciences Investors, LLC reported 24 holdings with total value $961 M as of Q3 2024. Top holdings included NUVL, NAMS, IRON, DNTH, and SVRA ... Q3 …

13f.info

$1.24
OFF

Bain Capital Life Sciences Investors, LLC - 13F

1 day from now

Feb 13, 2024 · Bain Capital Life Sciences Investors, LLC reported 26 holdings with total value $1.24 B as of Q1 2024. Top holdings included NAMS, NUVL, DNTH, IRON, and KYVERNA …

13f.info

$4.71
OFF

Bain Capital Investors 13F Annual Report (2024) | Wallmine

1 day from now

$4.71 trillion Assets Under Management (AUM) As of 5th August 2024, Bain Capital Investors’s top holding is 65,679,781 shares of Cerevel Therapeutics Hldng I currently worth over $2.69 …

wallmine.com

$1.24
OFF

Bain Capital Life Sciences Investors 13F Annual Report (2024 ...

1 day from now

Bain Capital Life Sciences Investors 13F annual report Bain Capital Life Sciences Investors is an investment fund managing more than $1.24 trillion ran by Adam Koppel. There are currently …

wallmine.com

0%
OFF

BAIN CAPITAL INVESTORS LLC Top 13F Holdings

1 day from now

Bain Capital Investors is based out of Boston. Their last reported 13F filing for Q3 2024 included $3,823,502,879 in managed 13F securities and a top 10 holdings concentration of 100.0%. …

whalewisdom.com

FAQs about Bain Capital Life Sciences Investors 13F annual report (2024 ... Coupon?

Who owns Bain Capital Life Sciences?

Bain Capital Life Sciences ("Bain Capital") led the transaction, while existing investor Vivo Capital remains a key shareholder in the company. ...

Is Bain Capital Investors a 13F stock?

Their last reported 13F filing for Q1 2023 included $5,493,265,000 in managed 13F securities and a top 10 holdings concentration of 100.0%. Bain Capital Investors's largest holding is Surgery Partners Inc with shares held of 58,248,249. Bain Capital Investors has met the qualifications for inclusion in our WhaleScore system. ...

How much did Bain Capital Life Sciences invest in its 4th fund?

Bain Capital Life Sciences said Tuesday it has secured about $3 billion for its fourth fund, bringing the private investment firm’s total haul since its 2016 inception to $6.7 billion. ...

Who is Bain Capital Investors?

Bain Capital Investors's largest holding is Surgery Partners Inc with shares held of 58,248,249. Bain Capital Investors has met the qualifications for inclusion in our WhaleScore system. Whalewisdom has at least 82 13F filings, and 21 Form 4 filings ...

What types of investment opportunities does Bain Capital Life Sciences target?

We target four types of investment opportunities: Inflection Capital; Growth Capital; Fallen Angels; and Larger Private Equity Collaborations and New Company Formation. Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe. ...

Who advises Bain Capital Specialty Finance?

Bain Capital Specialty Finance, Inc. is advised by BCSF Advisors, LP (“BCSF Advisors”). BCSF Advisors is an SEC-registered investment adviser and an affiliate of Bain Capital Credit, LP (“Bain Capital Credit”). ...